We posted last week about the Lone Pine order entered in the Celebrex litigation, and we received a few responses to that post.
Then we saw the letter from six drug companies to FASB, about which we posted on Friday.
The combination of those two things got us to thinking.
And if we’ve bothered
We were pleased to see that Judge Breyer has entered a so-called “Lone Pine” order in the Celebrex multidistrict litigation. Here’s a link to the order.
Lone Pine was a New Jersey state court case in which the judge ordered plaintiffs to offer proof connecting the defendant’s product to the plaintiff’s alleged injury.